400 related articles for article (PubMed ID: 21735432)
21. Intratympanic mixture gentamicin and dexamethasone versus dexamethasone for unilateral Meniere's disease.
Öztürk K; Ata N
Am J Otolaryngol; 2019; 40(5):711-714. PubMed ID: 31262549
[TBL] [Abstract][Full Text] [Related]
22. [Intratympanic corticosteroid perfusion in the therapy of Meniere's disease].
Sanković-Babić S; Kosanović R; Ivanković Z; Babac S; Tatović M
Srp Arh Celok Lek; 2014; 142(5-6):291-5. PubMed ID: 25033583
[TBL] [Abstract][Full Text] [Related]
23. Response Over Time of Vertigo Spells to Intratympanic Dexamethasone Treatment in Meniere's Disease Patients.
Atrache Al Attrache N; Krstulovic C; Pérez Guillen V; Morera Pérez C; Pérez Garrigues H
J Int Adv Otol; 2016 Apr; 12(1):92-7. PubMed ID: 27340991
[TBL] [Abstract][Full Text] [Related]
24. Long-term hearing outcome in patients receiving intratympanic gentamicin for Ménière's disease.
Wu IC; Minor LB
Laryngoscope; 2003 May; 113(5):815-20. PubMed ID: 12792316
[TBL] [Abstract][Full Text] [Related]
25. Systematic review of intratympanic gentamicin in Meniere's disease.
Diamond C; O'Connell DA; Hornig JD; Liu R
J Otolaryngol; 2003 Dec; 32(6):351-61. PubMed ID: 14967079
[TBL] [Abstract][Full Text] [Related]
26. Different medications for the treatment of Ménière's disease by intratympanic injection: A systematic review and network meta-analysis.
Cao Z; Yue F; Huang W; Rajenderkumar D; Zhao F
Clin Otolaryngol; 2019 Jul; 44(4):619-627. PubMed ID: 31025490
[TBL] [Abstract][Full Text] [Related]
27. Repetitive transcranial magnetic stimulation for tinnitus.
Meng Z; Liu S; Zheng Y; Phillips JS
Cochrane Database Syst Rev; 2011 Oct; (10):CD007946. PubMed ID: 21975776
[TBL] [Abstract][Full Text] [Related]
28. Efficacy of Intratympanic OTO-104 for the Treatment of Ménière's Disease: The Outcome of Three Randomized, Double-Blind, Placebo-Controlled Studies.
Phillips J; Mikulec AA; Robinson JM; Skarinsky D; Anderson JJ
Otol Neurotol; 2023 Jul; 44(6):584-592. PubMed ID: 37185596
[TBL] [Abstract][Full Text] [Related]
29. Intratympanic gentamicin for control of vertigo in Meniere's disease: vestibular signs that specify completion of therapy.
Minor LB
Am J Otol; 1999 Mar; 20(2):209-19. PubMed ID: 10100525
[TBL] [Abstract][Full Text] [Related]
30. Betahistine in Ménière's Disease or Syndrome: A Systematic Review.
Van Esch B; van der Zaag-Loonen H; Bruintjes T; van Benthem PP
Audiol Neurootol; 2022; 27(1):1-33. PubMed ID: 34233329
[TBL] [Abstract][Full Text] [Related]
31. A randomized, double-blind, placebo-controlled clinical study to assess safety and clinical activity of OTO-104 given as a single intratympanic injection in patients with unilateral Ménière's disease.
Lambert PR; Nguyen S; Maxwell KS; Tucci DL; Lustig LR; Fletcher M; Bear M; Lebel C
Otol Neurotol; 2012 Sep; 33(7):1257-65. PubMed ID: 22858715
[TBL] [Abstract][Full Text] [Related]
32. Betahistine for Menière's disease or syndrome.
James AL; Burton MJ
Cochrane Database Syst Rev; 2001; 2001(1):CD001873. PubMed ID: 11279734
[TBL] [Abstract][Full Text] [Related]
33. Hearing results and quality of life after streptomycin/dexamethasone perfusion for Meniere's disease.
Shea PF; Richey PA; Wan JY; Stevens SR
Laryngoscope; 2012 Jan; 122(1):204-11. PubMed ID: 22183636
[TBL] [Abstract][Full Text] [Related]
34. Dexamethasone inner ear perfusion for the treatment of Meniere's disease: a prospective, randomized, double-blind, crossover trial.
Silverstein H; Isaacson JE; Olds MJ; Rowan PT; Rosenberg S
Am J Otol; 1998 Mar; 19(2):196-201. PubMed ID: 9520056
[TBL] [Abstract][Full Text] [Related]
35. Differences in responsiveness of intratympanic steroid injection for intractable vertigo in Meniere's disease.
Okuda H; Aoki M; Ogawa B; Shibata H; Ueda N; Ohashi T; Hayashi H; Nishihori T; Kuze B; Ogawa T
Am J Otolaryngol; 2021; 42(6):103141. PubMed ID: 34171697
[TBL] [Abstract][Full Text] [Related]
36. Intratympanic Triamcinolone and Dexamethasone in the Treatment of Ménière's Syndrome.
Jumaily M; Faraji F; Mikulec AA
Otol Neurotol; 2017 Mar; 38(3):386-391. PubMed ID: 28192380
[TBL] [Abstract][Full Text] [Related]
37. The Follow-Up Role of the Vestibular Evoked Myogenic Potential Test in Meniere's Disease.
Yazdani N; Nejadian F; Rezazadeh N; Hoseinabadi R; Karimi E; Gharibi R; Dabiri S
Acta Med Iran; 2018 Jan; 56(1):43-48. PubMed ID: 29436794
[TBL] [Abstract][Full Text] [Related]
38. Transitory effect on endolymphatic hydrops of the intratympanic steroids for Ménière's disease.
Martin-Sanz E; Esteban-Sanchez J; Rodrigañez-Riesco L; Sanz-Fernández R
Laryngoscope; 2015 May; 125(5):1183-8. PubMed ID: 25429741
[TBL] [Abstract][Full Text] [Related]
39. Intratympanic Dexamethasone in the Treatment of Ménière's Disease: A Comparison of Two Techniques.
Beyea JA; Instrum RS; Agrawal SK; Parnes LS
Otol Neurotol; 2017 Jul; 38(6):e173-e178. PubMed ID: 28437363
[TBL] [Abstract][Full Text] [Related]
40. [Intratympanic treatment in Meniere's disease: the effect of gentamicin and dexamethasone on vertigo control and hearing].
Akkuzu B; Ozgirgin N; Ozlüoğlu LN
Kulak Burun Bogaz Ihtis Derg; 2006; 16(5):193-9. PubMed ID: 17124437
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
